echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > New urine test technology helps improve the efficiency of prostate cancer detection

    New urine test technology helps improve the efficiency of prostate cancer detection

    • Last Update: 2021-05-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    New urine test technology helps improve the efficiency of prostate cancer detection
    New urine test technology helps improve the efficiency of prostate cancer detection New urine test technology helps improve the efficiency of prostate cancer detection

    Xinhua News Agency, London, April 27 (Reporter Zhang Jiawei) The University of East Anglia in the United Kingdom released a study on the 27th, saying that an experimental urine test developed by its researchers has the potential to improve the efficiency of prostate cancer detection and make doctors understand more quickly The extent of the disease and whether in-depth testing is required to reduce the risk of patients being overdiagnosed and overtreated.


    Prostate cancer usually develops slowly, and the detection techniques currently used include blood tests, MRI scans, and prostate biopsy.


    The urinalysis technology developed by researchers at the school comprehensively evaluates the expression levels of a protein marker called EN2 and 10 genes related to prostate cancer risk.


    The results show that the new detection technology can successfully analyze which patient has prostate cancer, and can form relevant risk indicators for each patient, so as to tell the doctors which of them need further prostate biopsy to avoid The patient is overdiagnosed and overtreated.


    Darn Brewer, a researcher at the University of East Anglia who led the study, said that invasive prostate biopsy will impose a greater burden on patients in economic and psychological aspects, and will also bring higher costs to the medical system.


    The results of this research have been published in the latest issue of the British journal Cancer.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.